Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
FIBROGEN INC (FGEN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
4
| Schoeneck James A (Director) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 10,000 options to buy
@ $1.44, valued at
$14.4k
|
|
| 08/09/2023 |
4
| Wettig Thane (Chief Commercial Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 200,000 shares
@ $0
Granted 300,000 options to buy
@ $1.77, valued at
$531k
|
|
| 08/08/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2023 |
4
| Henderson Jeffrey William (Director) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 2,000 shares
@ $2.69, valued at
$5.4k
|
|
| 07/10/2023 |
4
| Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 1,880 shares
@ $2.8, valued at
$5.3k
|
|
| 06/15/2023 |
4
| Chung Christine (SVP, China Operations) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 6,250 shares
@ $17.6, valued at
$110k
Sold 5,250 shares
@ $16.66, valued at
$87.5k
Sold 1,000 shares
@ $17.46, valued at
$17.5k
|
|
| 06/09/2023 |
4
| Cravatt Benjamin (Director) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 8,289 shares
@ $0
Sold 1,766 shares
@ $16.75, valued at
$29.6k
Sold 2,178 shares
@ $17.51, valued at
$38.1k
Granted 12,666 options to buy
@ $17.13, valued at
$217k
|
|
| 06/09/2023 |
4
| Brennan Aoife (Director) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 8,289 shares
@ $0
Sold 1,994 shares
@ $16.74, valued at
$33.4k
Sold 2,739 shares
@ $17.52, valued at
$48k
Granted 12,666 options to buy
@ $17.13, valued at
$217k
|
|
| 06/09/2023 |
4
| Blaug Suzanne (Director) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 8,289 shares
@ $0
Sold 3,351 shares
@ $16.73, valued at
$56.1k
Sold 5,169 shares
@ $17.51, valued at
$90.5k
Granted 12,666 options to buy
@ $17.13, valued at
$217k
|
|
| 06/09/2023 |
4
| Ho Maykin (Director) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 8,289 shares
@ $0
Sold 2,295 shares
@ $16.79, valued at
$38.5k
Sold 6,225 shares
@ $17.68, valued at
$110.1k
Granted 12,666 options to buy
@ $17.13, valued at
$217k
|
|
| 06/09/2023 |
4
| Lema Gerald (Director) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 8,289 shares
@ $0
Granted 12,666 options to buy
@ $17.13, valued at
$217k
|
|
| 06/09/2023 |
4
| EDWARDS JEFFREY L (Director) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 8,289 shares
@ $0
Sold 3,265 shares
@ $16.74, valued at
$54.7k
Sold 4,624 shares
@ $17.51, valued at
$81k
Granted 12,666 options to buy
@ $17.13, valued at
$217k
|
|
| 06/09/2023 |
4
| Henderson Jeffrey William (Director) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 8,289 shares
@ $0
Sold 2,006 shares
@ $16.87, valued at
$33.8k
Sold 4,994 shares
@ $17.69, valued at
$88.3k
Granted 12,666 options to buy
@ $17.13, valued at
$217k
|
|
| 06/09/2023 |
4
| Schoeneck James A (Director) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 8,289 shares
@ $0
Sold 7,100 shares
@ $18.0264, valued at
$128k
Granted 12,666 options to buy
@ $17.13, valued at
$217k
|
|
| 06/09/2023 |
4
| Wettig Thane (Chief Commercial Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 472 shares
@ $17.0356, valued at
$8k
Sold 1,286 shares
@ $17.0377, valued at
$21.9k
|
|
| 06/09/2023 |
4
| Graham Juan (CFO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 1,050 shares
@ $16.9494, valued at
$17.8k
Sold 735 shares
@ $17.0383, valued at
$12.5k
|
|
| 06/09/2023 |
4
| Chung Christine (SVP, China Operations) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 1,362 shares
@ $17.0353, valued at
$23.2k
Sold 739 shares
@ $17.0363, valued at
$12.6k
Sold 1,532 shares
@ $17.0376, valued at
$26.1k
|
|
| 06/09/2023 |
4
| Eisner Mark (EVP, Chief Medical Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 2,042 shares
@ $17.038, valued at
$34.8k
|
|
| 06/09/2023 |
4
| Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 2,791 shares
@ $17.0368, valued at
$47.5k
Sold 6,106 shares
@ $17.0379, valued at
$104k
|
|
| 04/06/2023 |
4
| Eisner Mark (Chief Medical Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 9,182 shares
@ $18.7838, valued at
$172.5k
|
|
| 04/06/2023 |
4
| Chung Christine (SVP, China Operations) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 6,590 shares
@ $18.7838, valued at
$123.8k
|
|
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/24/2023 |
4
| Wettig Thane (Chief Commercial Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 905 shares
@ $18.71, valued at
$16.9k
|
|
| 03/10/2023 |
4
| Chung Christine (SVP, China Operations) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 8,354 shares
@ $21.1559, valued at
$176.7k
Granted 5,799 shares
@ $0
Granted 9,338 shares
@ $0
Sold 4,692 shares
@ $20.1973, valued at
$94.8k
Sold 2,914 shares
@ $20.1973, valued at
$58.9k
|
|
| 03/10/2023 |
4
| Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 24,672 shares
@ $21.1559, valued at
$522k
Granted 23,120 shares
@ $0
Granted 37,229 shares
@ $0
Sold 12,103 shares
@ $20.1973, valued at
$244.4k
Sold 19,486 shares
@ $20.1973, valued at
$393.6k
|
|
| 03/10/2023 |
4
| Eisner Mark (Chief Medical Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 7,363 shares
@ $21.1559, valued at
$155.8k
Granted 7,732 shares
@ $0
Granted 12,451 shares
@ $0
Sold 3,885 shares
@ $20.1973, valued at
$78.5k
Sold 6,255 shares
@ $20.1973, valued at
$126.3k
|
|
| 03/10/2023 |
4
| Graham Juan (CFO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 2,749 shares
@ $21.1559, valued at
$58.2k
Granted 2,899 shares
@ $0
Granted 4,668 shares
@ $0
Sold 1,112 shares
@ $20.1973, valued at
$22.5k
Sold 1,456 shares
@ $20.1973, valued at
$29.4k
Sold 2,344 shares
@ $20.1973, valued at
$47.3k
|
|
| 03/10/2023 |
4
| Wettig Thane (Chief Commercial Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 6,265 shares
@ $21.1559, valued at
$132.5k
Granted 5,799 shares
@ $0
Granted 9,338 shares
@ $0
Sold 2,938 shares
@ $20.1973, valued at
$59.3k
Sold 4,731 shares
@ $20.1973, valued at
$95.6k
|
|
| 03/06/2023 |
4
| Eisner Mark (Chief Medical Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 1,187 shares
@ $21.87, valued at
$26k
|
|
| 02/23/2023 |
4
| Wettig Thane (Chief Commercial Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 42,000 options to buy
@ $22.6, valued at
$949.2k
|
|
| 02/23/2023 |
4
| Graham Juan (CFO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 42,000 options to buy
@ $22.6, valued at
$949.2k
|
|
| 02/23/2023 |
4
| Chung Christine (SVP, China Operations) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 42,000 options to buy
@ $22.6, valued at
$949.2k
|
|
| 02/23/2023 |
4
| Eisner Mark (Chief Medical Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 32,500 shares
@ $0
Granted 55,000 options to buy
@ $22.6, valued at
$1.2M
|
|
| 02/23/2023 |
4
| Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 85,300 shares
@ $0
Granted 143,100 options to buy
@ $22.6, valued at
$3.2M
|
|
|
|
|